Recent progress in neuronal intranuclear inclusion disease: a review of the literature.

Biopsy Dementia Diffusion-weighted-imaging Neuronal intranuclear inclusion disease Ubiquitin

Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
May 2020
Historique:
received: 13 08 2019
accepted: 10 12 2019
pubmed: 4 1 2020
medline: 9 2 2021
entrez: 4 1 2020
Statut: ppublish

Résumé

To summarize the current understanding of neuronal intranuclear inclusion disease (NIID) and improve the understanding of the physician about this condition. We searched PubMed with keywords related to NIID and selected publications which seemed appropriate. We analyzed its clinical features, pathogenesis, evaluation methods, treatment options, and research prospectives. NIID is a degenerative condition which can affect multiple organ systems especially central nervous system. Its clinical features greatly vary, and making the exact diagnosis is often difficult. There are several genes which have been associated with this disorder. Some specific signs on diffusion-weighted-imaging (DWI) sequence of magnetic resonance (MR) imaging are characteristics to NIID. Intranuclear inclusions have been found in various nonneural cells of the body; therefore, the term systemic intranuclear inclusion disease is, perhaps, better suited to explain this disorder. There are several disorders which need to be ruled out before making the diagnosis, and neuroimaging and biopsy analysis should be combined to support the diagnosis.

Identifiants

pubmed: 31897935
doi: 10.1007/s10072-019-04195-6
pii: 10.1007/s10072-019-04195-6
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1019-1025

Auteurs

Hafiz Khuram Raza (HK)

Department of Neurology, Affiliated Hospital of Xuzhou Medical University, 221002, Xuzhou, P.R. China.

Sandeep Singh (S)

School of International Education, Xuzhou Medical University, 221002, Xuzhou, P.R. China.

Pabitra Rai (P)

School of International Education, Xuzhou Medical University, 221002, Xuzhou, P.R. China.

Thitsavanh Chansysouphanthong (T)

School of International Education, Xuzhou Medical University, 221002, Xuzhou, P.R. China.

Arooj Amir (A)

Central Park Medical College, Lahore, Pakistan.

Guiyun Cui (G)

Department of Neurology, Affiliated Hospital of Xuzhou Medical University, 221002, Xuzhou, P.R. China. cuiguiyun-js@hotmail.com.

Wenjing Song (W)

Department of Neurology, Affiliated Hospital of Xuzhou Medical University, 221002, Xuzhou, P.R. China.

Lei Bao (L)

Department of Neurology, Affiliated Hospital of Xuzhou Medical University, 221002, Xuzhou, P.R. China.

Su Zhou (S)

Department of Neurology, Affiliated Hospital of Xuzhou Medical University, 221002, Xuzhou, P.R. China.

Hongjuan Shi (H)

Department of Neurology, Affiliated Hospital of Xuzhou Medical University, 221002, Xuzhou, P.R. China.

Hao Chen (H)

Department of Neurology, Affiliated Hospital of Xuzhou Medical University, 221002, Xuzhou, P.R. China. haochen-2008@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH